Reports of MaLAM's activities and impact have been published in the Lancet, the British Medical Journal and elsewhere. Receive MaLAM International News. Have the opportunity to influence drug marketing. Subscribing to MaLAM is a fascinating way to learn important facts about therapeutics which are not always available elsewhere. MaLAM helps subscribers look more critically at the information which comes from the pharmaceutical industry.
More critical analysis assists the selection of better therapy.
This is where we'll announce the most recent additions to our web site. If you've visited us before and want to know what's changed, take a look there first. We are keen to hear from you. International Editions S ummaries of all international MaLAM editions published since January 1995. The full text of some editions are available.